 |
市場調查報告書
商品編碼
1673058
腎上腺素市場按產品類型、應用、分銷管道和地區分類Epinephrine Market, By Product Type, By Application, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
2025 年全球腎上腺素市場規模估計為 32.5 億美元，預計到 2032 年將達到 71.1 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 11.8%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 32.5億美元 |
| 效能資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025 年至 2032 年複合年成長率 | 11.80％ | 2032 年金額預測 | 71.1億美元 |
數字。 2025 年腎上腺素市場佔有率（按地區）
腎上腺素是一種荷爾蒙和藥物，用於治療許多疾病，包括過敏反應、心臟麻痹和表皮出血。作為一種注射藥物，它用於治療血管性水腫和過敏反應等過敏反應。它也可以用於預防因運動引起支氣管收縮的人的氣喘發作。氣喘等疾病的增加可能會增加對腎上腺素自動注射器的需求。腎上腺素成為過敏反應的標準治療方法，加上自動注射器的技術進步，可能會推動市場成長。
市場動態
全球腎上腺素市場的成長受到多種因素的推動，例如過敏反應和過敏反應發病率的增加、自動注射器技術的進步提高了給藥的便利性、緊急醫療環境的需求不斷增加以及腎上腺素自動注射器作為過敏反應的一線治療手段的應用日益廣泛。然而，自動注射器高成本、注射腎上腺素短缺導致價格上漲以及對替代治療方案的偏好等因素可能會阻礙市場成長。生物相似藥腎上腺素的出現及其在新興市場的滲透可以在預測期內為市場參與企業提供成長機會。
研究的主要特點
- 本報告對全球腎上腺素市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。
- 它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
- 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
- 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球腎上腺素市場的主要企業。
- 本報告的見解有望使負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球腎上腺素市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 透過分析全球腎上腺素市場所使用的各種策略矩陣，相關人員可以更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- 一致的機會圖 (COM)
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 市場趨勢
- 監管情景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
4. 全球腎上腺素市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
5. 2020-2032 年全球腎上腺素市場（按產品類型分類）（十億美元）
- 介紹
- 自動注射器
- 預填充式注射器
- 安瓿瓶與管瓶
6. 2020 年至 2032 年全球腎上腺素市場（按應用分類）（十億美元）
- 介紹
- 過敏反應
- 心臟麻痹
- 表皮出血
- 呼吸系統疾病
- 其他
7. 2020-2032 年全球腎上腺素市場按通路分類（十億美元）
- 介紹
- 醫院藥房
- 零售藥局
- 網路藥局
8. 2020 年至 2032 年全球腎上腺素市場（按地區分類）（十億美元）
- 介紹
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- 公司簡介
- Pfizer
- Harvest Pharmaceuticals
- Grand Pharma
- Lincoln Medical, Ltd.
- Abbott Laboratories
- Sanofi SA
- Mylan, Inc.
- ALK Abello A/S
- Amedra Pharmaceuticals LLC
- Impax
- Emerade
- Tianjin Jinyao Group
- Sandoz Inc.
- Bausch Health Companies Inc.
- Emerade
- Antares Pharma Inc.
第 10 章分析師建議
- 興衰
- 一致的機會地圖
第 11 章 參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI2401
Global Epinephrine Market is estimated to be valued at USD 3.25 Bn in 2025 and is expected to reach USD 7.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.25 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.80% | 2032 Value Projection: | USD 7.11 Bn |
Figure. Epinephrine Market Share (%), By Region 2025
Epinephrine, also known as adrenaline, is a hormone and medication that is used to treat a number of medical conditions such as anaphylaxis, cardiac arrest, and superficial bleeding. As an injection, it is used to treat allergic reactions like angioedema or anaphylaxis. It may also be used by people with exercise-induced bronchoconstriction to prevent asthma attacks. Rising diseases like asthma can boost demand for epinephrine auto-injectors. Emergence of epinephrine as the standard treatment for anaphylaxis along with technological advancements in autoinjectors can drive the market growth.
Market Dynamics:
Global epinephrine market growth is driven by factors such as rising incidences of anaphylaxis and allergic reactions, technological advancements in auto-injectors improving ease of administration, increasing demand from emergency medical settings, and growing adoption of epinephrine auto-injectors as the first line treatment for anaphylaxis. However, factors such as high costs associated with auto-injectors, shortage of injectable epinephrine exacerbating prices, and preference for alternative therapeutic options can hamper the market growth. Emergence of biosimilar epinephrine and expansion into developing regions can offer growth opportunities for market players during the forecast period.
Key Features of the Study:
- This report provides in-depth analysis of the global epinephrine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global epinephrine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Mylan N.V., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Impax Laboratories, LLC, Kaleo, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global epinephrine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global epinephrine market.
Detailed Segmentation-
- By Product Type
- Auto-injector
- Prefilled Syringes
- Ampoules and Vials
- By Application
- Anaphylaxis
- Cardiac Arrest
- Superficial Bleeding
- Respiratory Disorders
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Pfizer
- Harvest Pharmaceuticals
- Grand Pharma
- Lincoln Medical, Ltd.
- Abbott Laboratories
- Sanofi S.A.
- Mylan, Inc.
- ALK Abello A/S
- Amedra Pharmaceuticals LLC
- Impax
- Emerade
- Tianjin Jinyao Group
- Sandoz Inc.
- Bausch Health Companies Inc.
- Antares Pharma Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Epinephrine Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Epinephrine Market, By Product Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Auto-injector
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prefilled Syringes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ampoules and Vials
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Epinephrine Market, By Application, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Anaphylaxis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiac Arrest
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Superficial Bleeding
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Respiratory Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Epinephrine Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Epinephrine Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Pfizer
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Harvest Pharmaceuticals
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Grand Pharma
- Lincoln Medical, Ltd.
- Abbott Laboratories
- Sanofi S.A.
- Mylan, Inc.
- ALK Abello A/S
- Amedra Pharmaceuticals LLC
- Impax
- Emerade
- Tianjin Jinyao Group
- Sandoz Inc.
- Bausch Health Companies Inc.
- Emerade
- Antares Pharma Inc.
- Pfizer
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
